These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Cerebrospinal fluid complement activation in patients with pneumococcal and meningococcal meningitis. Mook-Kanamori BB; Brouwer MC; Geldhoff M; Ende Av; van de Beek D J Infect; 2014 Jun; 68(6):542-7. PubMed ID: 24412248 [TBL] [Abstract][Full Text] [Related]
33. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis. Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467 [TBL] [Abstract][Full Text] [Related]
34. Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis. Gelibter S; Pisa M; Croese T; Finardi A; Mandelli A; Sangalli F; Colombo B; Martinelli V; Comi G; Filippi M; Furlan R Ann Neurol; 2021 Aug; 90(2):253-265. PubMed ID: 34216397 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of free light chains lambda and kappa in early multiple sclerosis. Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552 [TBL] [Abstract][Full Text] [Related]
36. Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Evangelopoulos ME; Koutsis G; Boufidou F; Markianos M Neurobiol Dis; 2022 Nov; 174():105889. PubMed ID: 36209949 [TBL] [Abstract][Full Text] [Related]
37. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression. Teunissen CE; Sombekke M; van Winsen L; Killestein J; Barkhof F; Polman CH; Dijkstra CD; Blankenstein MA; Pratico D Mult Scler; 2012 Aug; 18(8):1092-8. PubMed ID: 22695538 [TBL] [Abstract][Full Text] [Related]
38. Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis. Martínez MA; Olsson B; Bau L; Matas E; Cobo Calvo Á; Andreasson U; Blennow K; Romero-Pinel L; Martínez-Yélamos S; Zetterberg H Mult Scler; 2015 Apr; 21(5):550-61. PubMed ID: 25732842 [TBL] [Abstract][Full Text] [Related]
39. Cisterno-lumbar gradient of complement fractions in geriatric patients with suspected normal pressure hydrocephalus. Seele J; Kirschfink M; Djukic M; Lange P; Gossner J; Bunkowski S; Wiltfang J; Nau R Clin Chim Acta; 2018 Nov; 486():1-7. PubMed ID: 30003878 [TBL] [Abstract][Full Text] [Related]
40. Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis. Börnsen L; Khademi M; Olsson T; Sørensen PS; Sellebjerg F Mult Scler; 2011 Jan; 17(1):32-42. PubMed ID: 20921238 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]